All Stories

  1. Evaluating Tissue-Agnostic Approvals in Thoracic and Head and Neck Malignancies
  2. Clinically Explainable Prediction of Immunotherapy Response Integrating Radiomics and Clinico-Pathological Information in Non-Small Cell Lung Cancer
  3. Dosing immune-checkpoint inhibitors: Opportunities for the future
  4. SUPE_R Surveillance? PET/CT in Post-Treatment NSCLC and the Imperative of Proof Before Practice
  5. Rationale for Investigation of Neoadjuvant Chemoimmunotherapy Before Chemoradiation in Unresectable Stage III Non–Small Cell Lung Cancer
  6. Tumor-Agnostic Therapies in Practice: Challenges, Innovations, and Future Perspectives
  7. Time to rethink platinum choices in the era of immunotherapy in lung cancer
  8. Author Correction: TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers
  9. TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers
  10. Current perspectives of KRAS in non-small cell lung cancer
  11. Plasma cfDNA in Carcinoma of unknown primary: A case series
  12. Data from Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
  13. Data from Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
  14. Supplementary Figures from Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
  15. Supplementary Figures from Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
  16. Supplementary Tables from Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
  17. Supplementary Tables from Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
  18. Paraganglioma of the Head and Neck: A Review
  19. Application of Value Framework to Phase III Trials of Immune Checkpoint Inhibitors in Esophageal and Gastric Cancer
  20. The contemporary management of cancers of the sinonasal tract in adults
  21. Assessing the risk of thromboembolism in cancer patients receiving immunotherapy
  22. Distinguishing granulomas from adenocarcinomas by integrating stable and discriminating radiomic features on non-contrast computed tomography scans
  23. Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
  24. Combination of Peri- and Intratumoral Radiomic Features on Baseline CT Scans Predicts Response to Chemotherapy in Lung Adenocarcinoma
  25. Mass Effect Deformation Heterogeneity (MEDH) on Gadolinium-contrast T1-weighted MRI is associated with decreased survival in patients with right cerebral hemisphere Glioblastoma: A feasibility study
  26. Shape Features of the Lesion Habitat to Differentiate Brain Tumor Progression from Pseudoprogression on Routine Multiparametric MRI: A Multisite Study
  27. Radiomics and radiogenomics in lung cancer: A review for the clinician
  28. Prostate shapes on pre-treatment MRI between prostate cancer patients who do and do not undergo biochemical recurrence are different: Preliminary Findings
  29. NIMG-80. SHAPE ATTRIBUTES OF ENHANCING LESION BOUNDARIES CAN DIFFERENTIATE TUMOR RECURRENCE FROM PSEUDO-PROGRESSION ON ROUTINE BRAIN MRI SCANS: PRELIMINARY FINDINGS
  30. Prediction of recurrence in early stage non-small cell lung cancer using computer extracted nuclear features from digital H&E images
  31. MEDU-48. MRI TEXTURAL FEATURES CAN DIFFERENTIATE PEDIATRIC POSTERIOR FOSSA TUMORS
  32. Seven versus 10 days antibiotic therapy for culture-proven neonatal sepsis: A randomised controlled trial
  33. Co-registration of pre-operative CT with ex vivo surgically excised ground glass nodules to define spatial extent of invasive adenocarcinoma on in vivo imaging: a proof-of-concept study
  34. FRMD4A/RET: A Novel RET Oncogenic Fusion Variant in Non–Small Cell Lung Carcinoma
  35. Field Effect Induced Organ Distension (FOrge) Features Predicting Biochemical Recurrence from Pre-treatment Prostate MRI
  36. Spur cell anemia in Wilson's disease: a rare presentation
  37. Crack cocaine–induced laryngeal injury: a case report
  38. Research letters
  39. Two Cases of NK/T Cell Lymphoma Presenting as Chronic Rhinosinusitis
  40. Burnout and Sleep Quality: A Cross-Sectional Questionnaire-Based Study of Medical and Non-Medical Students in India
  41. Porphyria cutanea tarda in a child with acute lymphoblastic leukemia
  42. Congenital anomaly
  43. Socio-economic profile of patients with community-acquired skin and soft tissue infections in Delhi
  44. Estimation of Gestational Age, Using Neonatal Anthropometry: A Cross-sectional Study in India
  45. Objective, Structured Proforma to Score the Merit of Scientific Presentations
  46. Case Reports
  47. Infective Gangrene in Extremity Trauma—Are We Targeting the Right Organisms?
  48. Congenital tuberculosis: a rare manifestation of a common disease
  49. Oral dextrose for analgesia in neonates during nasogastric tube insertion: A randomised controlled trial
  50. From the editors of a Student journal
  51. Costs of End-of-Life Care
  52. Psychomotor performance of medical students: Effect of 24 hours of sleep deprivation
  53. Leprosy and psoriasis co-existence
  54. Effect of caffeine on information processing: Evidence from stroop task
  55. Quality of life in patients with obsessive compulsive disorder: A longitudinal study from India